Follow

Chordate Medical Holding AB

Nasdaq First North GM Stockholm (Sweden)

Chordate Medical develops treatments for chronic nasal congestions through physical vibration. The vibration stimulates the nervous system, which in turn contracts the blood vessels in the nasal mucosa, which facilitates and creates space for air.
Go to market

Sector:
HEALTH CARE
>
Healthcare
Medical Devices & Instruments
Media
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Show archived

NB! Information about past events and all documents are available for signed in users who have bought those events.

Type
Ticker
ISIN
Market
SHARE
CMH
SE0009495559
Nasdaq First North GM Stockholm
Sweden (SE)
Details of share in Chordate Medical Holding AB with ticker CMH
Status
Active
Currency
SEK
First trading date
08 Mar 2017
Directed issue
Sign in to buy
Rights issue
Sign in to buy
Directed issue
Sign in to buy
Rights issue
Sign in to buy
Exercise
Sign in to buy
Directed issue
Sign in to buy
Rights issue
Sign in to buy
Directed issue
Sign in to buy
Exercise
Sign in to buy
Rights issue
Sign in to buy
Directed issue
Sign in to buy
Exercise
Sign in to buy
Exercise
Sign in to buy
Market move
Sign in to buy
Rights issue
Sign in to buy
Remuneration issue
Sign in to buy
Type
Ticker
ISIN
Market
SHARE
CMH
SE0009495559
Nasdaq First North GM Stockholm
Sweden (SE)
Details of share in Chordate Medical Holding AB with ticker CMH
Status
Active
Currency
SEK
First trading date
08 Mar 2017
Directed issue
Sign in to buy
Rights issue
Sign in to buy
Directed issue
Sign in to buy
Rights issue
Sign in to buy
Directed issue
Sign in to buy
Rights issue
Sign in to buy
Directed issue
Sign in to buy
Rights issue
Sign in to buy
Directed issue
Sign in to buy
Market move
Sign in to buy
Rights issue
Sign in to buy
Remuneration issue
Sign in to buy
Type
Ticker
ISIN
Market
OPTION
CHM MTF TO1
SE0011090901
Nasdaq First North GM Stockholm
Sweden (SE)
Details of option in Chordate Medical Holding AB with ticker CHM MTF TO1
Status
Archived
Currency
SEK
Trading period
18 Jul 2018 - 26 Jun 2019
Terms
Two (2) warrants entitles the holder to subscribe for one (1) new share for SEK 2.50 during the June 1, 2019 - June 28, 2019.
Exercise
Sign in to buy
Type
Ticker
ISIN
Market
OPTION
CMH TO3
SE0012453785
Nasdaq First North GM Stockholm
Sweden (SE)
Details of option in Chordate Medical Holding AB with ticker CMH TO3
Status
Archived
Currency
SEK
Segment
Nordic SME Sweden
Trading period
14 Jun 2019 - 27 May 2020
Terms
One (1) warrant entitles the holder to subscribe for one (1) new share for SEK 1.30.
Update (13.06.2019): First trading day for warrants TO3.
Exercise
Sign in to buy
Type
Ticker
ISIN
Market
OPTION
CMH TO5
SE0013358272
Nasdaq First North GM Stockholm
Sweden (SE)
Details of option in Chordate Medical Holding AB with ticker CMH TO5
Status
Archived
Currency
SEK
Segment
Nordic SME Sweden
Trading period
09 Jan 2020 - 28 Dec 2020
Terms
One (1) warrant entitles the holder to subscribe for one (1) new share for SEK 1.30.
Exercise
Sign in to buy
Type
Ticker
ISIN
Market
OPTION
CMH TO7
SE0014781951
Nasdaq First North GM Stockholm
Sweden (SE)
Details of option in Chordate Medical Holding AB with ticker CMH TO7
Status
Archived
Currency
SEK
Segment
Nordic SME Sweden
Trading period
14 Oct 2020 - 27 Oct 2021
Terms
One (1) warrant entitles the holder to subscribe for one (1) new share for SEK 0.75.
Update (06.10.2020): Information about warrants TO7.
Update (21.09.2021): Information about warrants TO7.
Exercise
Sign in to buy
People
Anders Henrik Weilandt
CEO
Nils Henrik Milton Rammer
Chairman of the board
Gunilla Ingeborg O Lundmark
Board member
Jan Tommy Lennart Hedberg
Board member
Anders Henrik Weilandt
Board member
Company Details
Sector
HEALTH CARE

Address
C/O Regus
Zip code
164 40
City/district
Kista
Country
Sweden (SE)
Registration number
556962-6319
LEI code
549300R0GG2J3S0BFN79
First trade date
08 Mar 2017
Registration date
22 Feb 2017
Short name
CMH

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More